Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.4053
-0.0418 (-9.35%)
At close: Oct 9, 2026, 4:00 PM EDT
0.4200
+0.0147 (3.63%)
After-hours: Oct 9, 2026, 7:52 PM EDT
Humacyte Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Humacyte stock has a consensus rating of "Buy" and an average price target of $1.63. The average 1-year stock price forecast is 302.17% higher than the current stock price, while the lowest is $0.50 (+23.37%) and the highest is $4.00 (+886.92%).
Price Target: $1.63 (+302.17%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Humacyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $0.5 | Hold | Maintains | $0.5 | +23.37% | Oct 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +886.92% | Sep 22, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $1.25 | Buy | Maintains | $1.25 | +208.41% | Aug 19, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $1 | Hold | Maintains | $1 | +146.73% | Aug 17, 2026 |
| BTIG | BTIG | Buy Maintains $2 | Buy | Maintains | $2 | +393.46% | Jul 29, 2026 |
Financial Forecast
Revenue This Year
3.51M
from 2.04M
Increased by 72.32%
Revenue Next Year
21.73M
from 3.51M
Increased by 518.79%
EPS This Year
-0.40
from -0.26
EPS Next Year
-0.25
from -0.40
EPS and Forward PE are based on non-GAAP adjusted numbers.